Skip to main content
Screener/Healthcare/Biotechnology

OVID Ovid Therapeutics Inc.

NASDAQ
$2.77+0.03 (+1.10%)
$0.27
$3.11
$2.70
$2.85
EPS (TTM)$-0.26
P/E Ratio-12.66
Dividend Yield
Market Cap$373.2M
Volume1.23M
Prev Close$2.73
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$718K$9.7M$0.1293.9%1346.0%
Q3 '25$132K-$12.2M$-0.1787.1%-9210.6%
Q2 '25$6.3M-$4.7M$-0.07100.0%-74.7%
Q1 '25$130K-$10.2M$-0.14100.0%-7873.1%
Q4 '24$76K-$9.3M$-0.13100.0%-12175.0%
Q3 '24$173K-$14.0M$-0.20100.0%-8096.0%
Q2 '24$169K$8.5M$0.12100.0%5042.0%
Q1 '24$148K-$11.7M$-0.17100.0%-7901.4%
Get Your Daily Market Recap